• SENSEX
    NIFTY 50
Healthcare

Bharat Biotech's COVID-19 vaccine Covaxin gets robust immune responses in animal trial

Updated : September 12, 2020 08:36 PM IST

Hyderabad-based Bharat Biotech on Friday released animal study results of COVID-19 vaccine candidate Covaxin.
Covaxin is currently in Phase I/II human trials.
The results show a reduction in replication of the virus in the nasal cavity, throat and lung tissues of monkeys.
Bharat Biotech's COVID-19 vaccine Covaxin gets robust immune responses in animal trial

You May Also Like

Live TV
Advertisement